Alyeska Investment Group, L.P. Bristol Myers Squibb CO Transaction History

Alyeska Investment Group, L.P.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	BUY	$59.34 - $66.74 $6.3 Million - $7.08 Million	106,126 Added 47.42%	329,935 $20.8 Million
Q4 2020 Feb 16, 2021	SELL	$57.74 - $65.43 $5.58 Million - $6.32 Million	-96,645 Reduced 30.16%	223,809 $13.9 Million
Q4 2018 Feb 14, 2019	SELL	$48.76 - $63.23 $33 Million - $42.8 Million	-677,578 Reduced 67.89%	320,454 $16.7 Million
Q1 2018 May 15, 2018	BUY	$59.92 - $68.98 $24.4 Million - $28.1 Million	407,698 Added 69.06%	998,032 $63.1 Million
Q4 2017 Feb 14, 2018	SELL	$59.94 - $65.35 $34.3 Million - $37.4 Million	-573,008 Reduced 49.26%	590,334 $36.2 Million
Q3 2017 Nov 14, 2017	BUY	$55.23 - $63.74 $64.3 Million - $74.2 Million	1,163,342	1,163,342 $74.2 Million

2,536

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $123B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Alyeska Investment Group, L.P., based on Form 13F filings with the SEC.

Stay updated on Alyeska Investment Group, L.P. with notifications on news.